One of the most important things a patient can do is see a true MPN Specialist, the … Learn More

MPN Information and Research Hub
by David Wallace https://youtu.be/vsk2OBtJmIs Dr. Ghaith Abu-Zeinah, Assistant Professor at Weill Cornell Medical College, Silver MPN Center is our MPN specialist … Continue Reading
Part 4 in a New Series: "Addressing MPN Symptoms" Prevalence of Chronic Pain and High-Impact Chronic Pain in Cancer Survivors in the United States Jiang C, Wang H, … Continue Reading
by David Wallace As some MPN patients are aware of firsthand, there are a number of autoimmune diseases that may run concurrently with the condition – while these … Continue Reading
by Marcy Worthington, Charla Billick, Christine Kelly Kennedy and multiple contributions from members of Facebook Support Group When we have an appointment scheduled … Continue Reading
Fighting MPN cancer? Be mindful of stress. by David Wallace If you have been diagnosed with MPN cancer, remember that it is just as important to take care of your … Continue Reading
How Can I Beat the Itchies? contributed by Paul Jaeger I was suffering from itching (pruritis) almost 10 years before my Polycythemia Vera was diagnosed. It's the … Continue Reading
PV Reporter was created to provide “easy access” to pertinent information on Polycythemia Vera (PV), Essential Thrombocythemia (ET) and Myelofibrosis (MF).
One of the most important things a patient can do is see a true MPN Specialist, the … Learn More
The Blog Page provides timely, relevant news items, research reports, “‘patient stories”, … Learn More
An Overview of Myeloproliferative Neoplasms A myeloproliferative neoplasm (MPN) … Learn More
MPN Search - Myeloproliferative Neoplasm (MPN) Custom Search of "Authority Sites" MPN … Learn More
This Podcast will cover many elements of my Polycythemia Vera (PV) journey, from the day … Learn More
Our fellow MPN Patients share their trials and tribulations with Polycythemia Vera, … Learn More
Would you like to speak with an Information Specialist to obtain information and resources … Learn More
This group is for people with myeloproliferative neoplasms (MPNs). MPNs include … Learn More
PharmaEssentia is the sponsor. This study is designed to assess the effectiveness and safety of two dosing regimens of ropeginterferon alfa-2b-njft (an accelerated titrated dosing versus the current recommended dosing) in adults with polycythemia vera (PV). Summary:ECLIPSE PV (NCT05481151) is a … Learn More
Protagonist Therapeutics is the sponsor. Rusfertide, also called PTG-300, is an investigational medication. Study participation will help evaluate how safe and effective rusfertide is in keeping the hematocrit levels within the recommended range to reduce the need for … Learn More
Unfortunately for some polycythemia vera (PV) patients, current treatment options may not be fully effective or well-tolerated and may cause serious side effects. But a promising investigational treatment is currently being clinically evaluated. Rusfertide, also known as PTG-300, is an investigational new drug designed to slow the release of iron into the bone marrow. The […]
Part 1 in our new “Rising Stars” series featuring – Dr. Tyler Parsons Written by Heidi Cascarano and David Wallace Early Blood Clot Mysteries Like many MPN patients, Tyler’s journey to diagnosis was a long and winding road, marked by mysterious symptoms that remained unexplained for years. For Tyler, these symptoms took the form of […]
A group of biomedical researchers from around the world, including Dr. Alexander Bick at Vanderbilt University Medical Center, have developed a new technique called PACER to measure the growth rate of abnormal blood stem cells. This breakthrough could help doctors reduce their patients future risk of blood cancer. Why This Matters: The Importance of Understanding […]
by David Wallace Understanding Thrombosis in MPN Patients Myeloproliferative neoplasms (MPNs) are a group of chronic blood cancers that affect the normal functioning of blood cells. People living with MPNs, such as polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis (MF), have an increased risk of developing blood clots, or thrombosis. Thrombosis can lead to […]
World-Renowned Physician-Scientist and Global Expert in Myeloproliferative Neoplasms Will Be Instrumental in Advancing the Development of Navtemadlin and Other Innovative Therapies to Improve the Lives of Cancer Patients REDWOOD CITY, Calif., March 02, 2023–(BUSINESS WIRE)–Kartos Therapeutics, Inc. (“Kartos” or the “Company”), a clinical stage biopharmaceutical company dedicated to the development of novel, targeted therapeutics that […]
PV Reporter was created to provide “easy access” to pertinent information on Polycythemia Vera (PV), Essential Thrombocythemia (ET) and Myelofibrosis (MF). These disorders are Myeloproliferative Neoplasms (MPNs), a closely related group of blood cancers where the bone marrow cells that produce the body’s blood cells function and develop abnormally.
If you are a newly diagnosed patient or researching MPNs, make PV Reporter your starting point. While many existing MPN websites provide excellent content, they tend to be internally focused or lack external search capabilities. PV Reporter solves that problem with MPN Search, a “custom search engine” retrieving exactly the information you are looking for!
Search for MPN Clinical Trials that may help you find new treatments and medical approaches for your myelofibrosis (MF), polycythemia vera (PV) or essential thrombocythemia (ET).
ClinicalTrials.gov is difficult to use for patients, as it is primarily a resource for doctors and clinicians. Our Clinical Trial Finder restructures the trial information - providing "easy access" while improving patient's understanding of the trial.